Medical device and MedTech insights, news, tips and more

Boston Scientific to Restructure, Expects $200M in Cut Costs

November 16, 2018

BSC_wtag_541blue_rgb

Boston Scientific said yesterday that it’s planning a three-year restructuring program that’s slated to cost at least $200 million.

The Marlborough, Mass.-based medical device maker said it expects to maintain roughly the same number of workers, although there will be some churn as new jobs are created.

“[T]he company does expect some employee attrition and limited headcount reductions to result from these restructuring activities,” the company said in a regulatory filing.

The changes, due to begin next year and proceed through 2021, are expected to cut annual pre-tax operating expenses by $100 million to $150 million by the end of 2022, Boston Scientific said, noting that it plans to put “a substantial portion” of the savings into “strategic growth initiatives.”

Termination benefits are expected to run between $75 million and $100 million, plus another $25 million to $50 million in fees and costs from spiking contracts, Boston said; another $100 million to $150 million in other restructuring costs are also in store, meaning the total cost could run as high as $300 million including $180 million to $280 million in expected cash outlays.

Read More at the Source: Boston Scientific plans $200m restructuring – MassDevice


Article Written by: Brad Perriello


A Speciality Recruiting Firm Exclusively Servicing The Medical Device Industry

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

 

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.